Search Results

Calm Prevails Around Iran's Bushehr Nuclear Power Plant

Alexey Likhachev, Director General of Rosatom, stated on August 22 that the situation in the area surrounding Iran's Bushehr Nuclear Power Plant remains calm. Speaking to reporters in Moscow, Likhachev said the Bushehr plant has remained largely quiet. He noted that over the past few months, no concerning incidents have occurred at the plant itself, in its vicinity, or in related towns. Located in southern Iran, the Bushehr Nuclear Power Plant is a key nuclear facility for the country. According to Likhachev, no abnormal signals have been detected in the operation and security situation of the plant and its surrounding areas.

2026-08-24

Russia Advances Development of Nuclear-Powered Underwater Natural Gas Carriers

Mikhail Kovalchuk, Director of the National Research Center Kurchatov Institute and Chairman of the Scientific Expert Council of the Russian Federation Maritime Board, recently stated that nuclear-powered underwater natural gas carriers could help Russia secure energy exports via the Northern Sea Route. Speaking at a joint meeting of the Ministry of Industry and Trade and the Ministry of Transport, Kovalchuk reported on the project's progress, noting that the first phase of development for this type of gas carrier has been completed, with the second phase currently underway. Gazprom has allocated dedicated funding for the project. Kovalchuk indicated that the development of such vessels holds significant...

2026-08-24

Atom High-Tech Adds New Radiopharmaceutical Production Base in Changchun

The Jilin Provincial Medical Products Administration issued a public notice on August 21 stating that, in accordance with the Drug Administration Law of the People's Republic of China, the Regulations on the Administration of Radiopharmaceuticals, the Measures for the Supervision and Administration of Drug Production, and other relevant provisions, following on-site inspection and review approval, it intends to issue the Radiopharmaceutical Production License to Changchun Atom High-Tech Pharmaceutical Co., Ltd. The public notice period is 5 working days, subject to public supervision. The notice information shows that the registered address of Changchun Atom High-Tech Pharmaceutical Co., Ltd. is located at No. 770 Shengye Road, Beihu Science and Technology Development Zone, Changchun City, Jilin Province, and the proposed production address for the license is consistent with the registered address. The proposed production scope for this license is small-volume injections for in vivo radiopharmaceuticals, involving products such as Sodium Pertechnetate [99mTc] Injection, Technetium [99mTc] Methylenediphosphonate Injection, Technetium [99mTc] Methoxyisonitrile Injection, Technetium [99mTc] Pentetate Injection, Technetium [99mTc] Ethyl Cysteinate Dimer Injection, and Technetium [99mTc] Etifenin Injection.

2026-08-24

Taishan Nuclear Power Achieves Full-Process Digitalization for Two Major Environmental Monitoring Inspections

Recently, the central station inspections of the Plant Environment and Meteorological Monitoring System (KRS) and the Hydrological and Water Quality Monitoring System (YSI) buoy inspections at Taishan Nuclear Power Plant have officially entered full-process digital operation, with all related inspection tasks integrated into the GFIS (Taishan Inspection Data Monitoring System) for online workflow, marking the end of the paper-based inspection sheet era. In the central station equipment room of the environmental laboratory, inspectors can complete online data entry and upload via mobile office devices after verifying data accuracy. △Inspection interface Previously, these two inspection tasks relied on paper-based recording, with inspection data manually transcribed on site and handed over offline for review, making real-time verification and sharing of information impossible. The mountains of paper forms not only made data retrieval time-consuming and laborious but also hindered equipment operation and maintenance quality assessments. Driven by the company's digital transformation initiative, these two inspection tasks have now embarked on the path of digitalization.

2026-08-24

Hengyang New Radiopharmaceutical Isotope and Drug Industrialization Project Officially Launched

On August 22, the groundbreaking ceremony for the Hengyang New Radiopharmaceutical Isotope and Drug Industrialization Project was held in Hengyang, Hunan Province. Officials from Hengyang City and Zhuhui District, representatives from relevant colleges of the University of South China, investment institutions, and relevant personnel from New Radiopharmaceutical Medical attended the event. Cai Jiming, Chairman and President of New Radiopharmaceutical Medical, stated at the ceremony that the project's landing in Hengyang represents an important strategic layout for the company's nuclear medicine business. From contract signing to construction commencement, the project has received support from local governments, partners, and relevant organizations. The company will leverage this project as an opportunity to continue advancing the transformation of innovative achievements in the fields of medical isotopes and radiopharmaceuticals. Wang Jing, Deputy Mayor of Hengyang City, stated that Hengyang...

2026-08-22

China Nuclear Power Industrial Internet Platform Optimization Project Passes Technical Acceptance

On August 18, China Nuclear Power organized the technical acceptance of the centralized R&D project "Optimization, Expansion, and Application Deepening Research of the Nuclear Power Industrial Internet Platform" in Wuhan. The expert panel reviewed the project team's report on the completion of project objectives, research content, technical indicators, and expected outcomes, examined the documentation, and after inquiry and discussion, unanimously agreed that the project has comprehensive research content, met technical indicators, achieved outstanding innovation results, demonstrated good pilot application effects, and maintained complete and standardized documentation, approving the technical acceptance. The Nuclear Power Industrial Internet Platform (DHP) serves as the solid group-level foundation for China Nuclear Power's digital development, undertaking the coordination of data element circulation across multiple bases and reactor types,...

2026-08-22

CNNC Particle and Beijing Institute of Medical Device Testing Carry Out Joint Learning and Co-building Activity

On August 20, CNNC Particle and the Beijing Institute of Medical Device Testing carried out a joint learning and co-building activity. Representatives from both sides engaged in in-depth discussions on topics such as Party building leading business development, joint development of technical standards, and enhancement of inspection and testing capabilities. Wu Wei, Secretary of the Party Branch and Director of CNNC Particle, Wu Kechun, Deputy Secretary of the Party Committee of the Institute, and more than twenty Party member representatives from both sides participated in the event. At the beginning of the event, the CNNC Particle delegation visited the Institute's laboratories to gain first-hand understanding of its technical capabilities and research progress in inspection and testing. The Institute's advanced experimental platforms and technologies left a deep impression on the visitors. During the discussion session, Wu Kechun and Wu Wei delivered speeches respectively. Both sides...

2026-08-22

Argentina's Nucleoeléctrica Argentina adjusts organizational structure to boost nuclear service exports

The Board of Directors of Nucleoeléctrica Argentina SA held a meeting on August 12, 2026, and approved Resolution No. 1018, authorizing adjustments to the company's organizational structure with a focus on supporting the development of new business units, particularly the export of specialized nuclear services to international markets. This adjustment provides organizational support for the company's earlier formal incorporation of "provision of services to foreign nuclear facilities" into its corporate purpose. In recent years, the company has participated in projects and services related to nuclear facilities in Canada, Brazil, China, South Korea, and Spain, and has developed proprietary technological solutions applicable to CANDU reactors. Under the new structure, the company's management...

2026-08-22

Cubresa Brain PET Scanner Receives FDA 510(k) Clearance, Integrates with Existing PET/MR Systems

Molecular imaging technology company Cubresa Inc. announced on August 20 that its Cubresa BrainPET™ scanner has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). According to the company, the Cubresa BrainPET™ is a positron emission tomography (PET) device specifically designed for brain imaging and can be integrated into existing Siemens Biograph mMR MR/PET systems. The device enables healthcare institutions to perform simultaneous PET/MR brain imaging on existing MRI infrastructure, capturing molecular and anatomical information without the need to purchase a separate whole-body hybrid imaging system. Cubresa founder and CEO James ...

2026-08-22

Portal Inspection and Screening System Tested at Chernyshevskoye Border Crossing on Russia-Lithuania Border

On August 20, the customs authorities of the Kaliningrad region of Russia, together with the equipment manufacturer, conducted functional tests of the portal inspection and screening system at the Chernyshevskoye border crossing on the Russia-Lithuania border, focusing on verifying equipment operational status and vehicle inspection capabilities. According to reports, among all Russian border crossings in the Kaliningrad region, only the Chernyshevskoye international road crossing is currently equipped with portal inspection and screening devices. A total of two systems have been installed at this crossing, used respectively for inspecting vehicles entering Russia and those departing, with both units installed and put into operation in December 2025. The inspection and demonstration were carried out with the participation of government regulatory authorities and supplier representatives. The relevant equipment is planned to be...

2026-08-22

US Boston Dynamics and UK Roke Expand Spot Robot Reconnaissance Applications for Nuclear Facilities

US-based Boston Dynamics is expanding its collaboration with overseas specialized defense solutions companies to promote the application of its quadruped robot Spot in industrial, defense, and high-risk operational scenarios. Leveraging Spot's mature mobile platform capabilities, the company aims to further enter industry sectors with high demand for unmanned operations by integrating software systems designed for reconnaissance in hazardous environments. Boston Dynamics' quadruped robot Spot is equipped with autonomous reconnaissance software SPROCKET developed by UK-based Roke. (Image courtesy of Roke) UK defense security R&D company Roke announced on the 22nd that it has deployed Spot quadruped...

2026-08-23

South Korea's Asan Medical Center Develops AI-Based Radiopharmaceutical Therapy Platform with U.S. Institutions

The research team at Asan Medical Center in Seoul announced on the 21st that it has recently been selected for the "2026 Korea-U.S. Innovative Outcomes R&D New Support Project" organized by the Ministry of Health and Welfare, and will collaborate with U.S. research institutions to develop an artificial intelligence-based radiopharmaceutical therapy platform aimed at exploring new treatment strategies for solid tumors that respond poorly to conventional therapies. The team is composed of professors including Myung Seung-jae from the Department of Gastroenterology, Oh Seung-jun from the Department of Nuclear Medicine, Ryu Chang-hoon from the Department of Oncology, Jung Byung-kwan from the Department of Pathology, and Son Byung-ho from the Department of Breast Surgery at Asan Medical Center. The project will combine Asan Medical Center's large-scale clinical and pathological data, Emory University's AI-based digital pathology analysis technology, and Case Western Reserve University and University Hospitals Cleveland Medical Center's pathological and clinical research capabilities.

2026-08-22

Two New Members Join the "Guohe One" Industrial Chain Alliance

On the afternoon of August 20, the signing ceremony for the co-construction agreement of the Guohe One Industrial Chain Alliance and the exchange meeting on new nuclear materials and technologies were held at Shanghai Research Institute of Materials Co., Ltd. Shanghai Nuclear Engineering Research and Design Institute Co., Ltd. signed the "Guohe One Industrial Chain Alliance Co-construction Agreement" with Shanghai Research Institute of Materials Co., Ltd. and Qingdao Keertai Environmental Control Technology Co., Ltd., marking the official accession of the two entities to the alliance. On the same day, the Nuclear Power Isolation, Vibration Reduction, and Wear Reduction Equipment Localization Development Center, led by Shanghai Research Institute of Materials Co., Ltd., was officially launched. The center will focus on localization development in areas such as isolation, vibration reduction, and wear reduction for key nuclear power equipment, promoting the transformation of related technologies from research and validation to engineering application.

2026-08-22

CFHI Dalian Nuclear Power Evaporator Clean Room Project Advances Preliminary Preparations

Recently, preliminary preparations are advancing for the clean room project under the evaporator batch manufacturing capacity building initiative of CFHI Dalian Nuclear Power & Petrochemical. Located in the Dalian Bay coastal equipment manufacturing cluster, the project will improve the clean operating conditions for nuclear power evaporator production and address the shortcomings in supporting processes for batch manufacturing. The project has a total investment of 18.81 million yuan, covering an area of approximately 2,600 square meters, with a new building area of approximately 2,600 square meters. The construction centers on the evaporator tube bundle assembly clean room, supplemented by installation workstations, channel head storage areas, packaging transport track systems, and air purification systems. Since the project launch, relevant departments in Dalian Bay have been providing service support for preliminary work including land planning, engineering scheme preparation, and approval coordination, while liaising with municipal and district-level industry authorities to resolve bottlenecks in project advancement and improve the efficiency of preliminary preparations.

2026-08-22

Research reactors provide critical support for global medical, scientific, and industrial innovation

The International Atomic Energy Agency recently reported that research reactors continue to play a vital role in medical, scientific, industrial innovation, and nuclear workforce development, serving as key infrastructure for many countries to build their nuclear science and technology capabilities. Currently, 228 research reactors are in operation across 54 countries worldwide, with another 23 under construction or in the planning stage. Unlike nuclear power reactors used for electricity generation, research reactors primarily produce neutrons for applications in medicine, industry, agriculture, geological sciences, forensics, and other fields. With capabilities such as neutron irradiation, neutron imaging, elemental analysis, and radioisotope production, research reactors have become important platforms for advancing peaceful nuclear technology applications. In the medical field, research...

2026-08-23